BRUCE GERALD W enters VIRPAX PHARMACEUTICALS, INC. with 4.04K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 2/16/2021ACC: 0001213900-21-009796
Director
Since Feb 2021
4.04K
Baseline shares
100% direct
4.04K
Direct ownership
1 position
15.17K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock, $0.00001 par value per share
DirectShares owned4.04K
Total
4.04K direct4.04K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.00001 par value per share | 4.04K | Direct |
| Total | 4.04K | 4.04K direct |
Derivative Holdings1
Stock Option (right to buy)
DirectUnderlying security
Common Stock, $0.00001 par value per share
Underlying shares
15.17K
Shares owned
N/A
Exercise price
9.89
Expiration
—
Exercise window
—
Total
Underlying
15.17K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock, $0.00001 par value per share | 9.89 | — | — | 15.17K | N/A |
| Total | 15.17K | 0.00 | ||||